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A B S T R A C T
Objectives: To compare genotypes of Mycobacterium bovis strains from humans in Southern California
with genotypes of M. bovis strains in cattle in Mexico and the USA to explore the possible origins of
human infections.
Methods: We conducted a descriptive analysis of M. bovis genotypes from a binational population of
humans and cattle using spacer oligonucleotide typing (spoligotyping).
Results: One hundred six human M. bovis spoligotypes were compared to spoligotypes from 496
Mexican cattle and 219 US cattle. Twelve spoligotype patterns were identiﬁed among human cases and
126 spoligotype patterns were detected in cattle. Over 91% (97/106) of the human M. bovis isolates had
spoligotypes that were identical to those found in Mexican cattle. Four human cases had spoligotypes
that matched both cattle born in Mexico and in the USA. Nine human cases had spoligotypes that did not
match cattle born in Mexico or the USA.
Conclusions: Our data indicate that the population of M. bovis strains causing human TB disease in
Southern California is closely related to the M. bovis strain population found in Mexican cattle and
supports existing epidemiological evidence that human M. bovis disease in San Diego likely originated
from Mexican cattle.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Tuberculosis (TB) is currently one of the leading causes of death
due to infectious disease globally, with 9.3 million incident cases
and over 1.7 million deaths reported in 2007.1 TB in humans is
caused mostly by Mycobacterium tuberculosis, but this was not
always the case. In the early 1900 s an estimated 30% of TB cases in
Europe were caused by the cattle TB pathogen, Mycobacterium
bovis,2 a closely relatedMycobacterium species largely transmitted
to humans via inhalation of infectious droplets from infected cattle
and consumption of contaminated, unpasteurized dairy products.3
The introduction of milk pasteurization and ‘test and slaughter’
cattle control programs in the early 1900 s all but eradicated M.
bovis from cattle and humans in most of the USA and other§ The ﬁndings and conclusions in this report are those of the authors and do not
necessarily represent the views of the Centers for Disease Control and Prevention.
* Corresponding author. Tel.: +1 858 822 4353.
E-mail address: trodwell@ucsd.edu (T.C. Rodwell).
1201-9712/$36.00 – see front matter  2010 International Society for Infectious Disea
doi:10.1016/j.ijid.2009.11.037developed nations.2,4 A recent study of all human TB cases in the
USA from 1995 through 2005 estimated that only 1.4% of cases
were still being caused by M. bovis, most of which were among
individuals born outside of the USA.5
However, in certain regions of the USA along the border with
Mexico, and inMexican-born individuals in NewYork City,M. bovis
TB prevalence has been shown to be signiﬁcantly higher than the
national prevalence.6–12 In San Diego, California in particular, over
45% of all culture-conﬁrmed TB cases in children and 8% of all TB
cases were recently found to be due to M. bovis.13
Epidemiological evidence suggests that M. bovis TB in Southern
California is largely the result of the consumption of unpasteurized
dairy products, such as unpasteurized cheese commonly referred to
as queso fresco, from infected cattle in Mexico,10,13–15 but evidence
linking the M. bovis pathogen populations in cattle and humans is
lacking. The aim of this studywas to utilizemolecular genotyping to
examine the relationshipsbetweenthepopulationofM.bovis strains
collected fromcattle inMexicoand theUSA, and thepopulationofM.
bovis strains isolated from human TB cases in San Diego.ses. Published by Elsevier Ltd. All rights reserved.
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2.1. Study design
We conducted a retrospective analysis of all known M. bovis
genotypes in humans from San Diego County, and a convenience
sample of genotypes from cattle in Mexico and the USA,
represented by spacer oligonucleotide types (spoligotypes). The
study protocol was approved by an Institutional Review Board at
the University of California, San Diego.
2.2. Data source
We obtained human M. bovis isolates from the San Diego
County Tuberculosis Surveillance Program for the years 2004
through 2007, which included all knownM. bovis TB cases.M. bovis
TB cases represented approximately 10% of all TB cases during that
period. All TB isolates from patient specimens were initially
identiﬁed as M. tuberculosis complex based on the AccuProbe
hybridization protection assay (GenProbe, San Diego, CA, USA). We
identiﬁed specimens as either M. bovis or M. tuberculosis based on
culture morphology, the results of the niacin strip test, the nitrate
reduction test and their susceptibility to pyrazinamide,16 and
conﬁrmed species designations with genotyping17 conducted by
the California Department of Public Health, Microbial Diseases
Laboratory.
M. bovis genotypes from cattle born inMexico were collected as
convenience samples as part of cattle TB surveillance efforts in
Mexico from 1997 through 2007.Mexican isolates were genotyped
by the Programa Nacional de Epidemiologı´a (CENIDFA-INIFAP) in
Mexico. We also obtained Mexican cattle M. bovis spoligotypes
from peer-reviewed, published studies14,18–24 listed in PubMed
from 1997 through 2008. To our knowledge these genotypes
represent all known reportedM. bovis genotypes by spoligotyping
from cattle in Mexico.
For this study, we also examined all available spoligotypes in
the US national surveillance database of M. bovis isolates sent to
the National Veterinary Services Laboratories (NVSL), Ames, Iowa
(US Department of Agriculture, Animal and Plant Health Inspection
Services) from 1997 through 2008. The NVSL surveillance database
represents a convenience sample of all cattle suspected of having
TB in the USA from 1997 to 2008.
2.3. Spoligotyping
Spoligotyping was performed independently in Mexico and in
the USA. Spoligotyping was performed by all laboratories using the
Spoligo Kit (Isogen Bioscience BV, Maarsen, the Netherlands) usingTable 1
Frequencies of spoligotype patterns forMycobacterium bovis cases reported in San Diego
USA
Spoligotype name Spoligotype (octal) No. of MIRU subtypesa Numb
SB0145 640013777777600 6 51 (48
SB1040 640013377777600 4 39 (36
SB1758 676573777776600 1 3 (2.8)
SB0673 264073777777600 2 2 (1.9)
SB0140 664073777777600 2 2 (1.9)
SB0152 400000077777600 1 2 (1.9)
SB1759 640013776377600 1 2 (1.9)
SB0971 664073777700600 1 1 (0.9)
SB1760 640012377777600 1 1 (0.9)
SB1761 640013357777600 1 1 (0.9)
SB1762 672573777777600 1 1 (0.9)
SB1345 676713677777600 1 1 (0.9)
Total 106
a Isolates were subtyped by mycobacterial interspersed repetitive units (MIRU) analstandard methods described in detail in Kamerbeek et al.25 Brieﬂy,
the direct repeat (DR) region of theM. bovis genome was ampliﬁed
using a polymerase chain reaction (PCR), then probed for the
presence or absence of 43 different spacer sequences using a dot
blot method. Primers were labeled with biotin, and ampliﬁed
products were detected using a streptavidin–POD conjugate
(Boehringer Mannheim, Mannheim, Germany) or a chemilumi-
nescent detection system (Amersham ECL, Rockford, IL, USA) with
X-ray ﬁlm.
2.4. Mycobacterial interspersed repeat units (MIRU)
Spoligotypes of M. bovis isolates from humans in San Diego
County were further subtyped by MIRU typing as described
elsewhere.26–28 Brieﬂy, loci consisting ofmultiple copies of tandem
repeats distributed around the M. bovis chromosome were
ampliﬁed by PCR before reactions were multiplexed and fragment
lengths were evaluated using a capillary sequencer. The standard
20-locus set was tested. Cattle spoligotypes were not further
subdivided by MIRU genotyping as MIRU data were not available
for the cattle isolates and isolates are no longer available for
testing.
2.5. Data management and analysis
We converted all spoligotype data to a 15-digit number using
an octal coding system and compiled the data into a database using
MS Excel software (Microsoft, Seattle, WA, USA). Each spoligotype
was cataloged with a unique identiﬁer along with information on
its source (human or cattle), cattle breeding purpose (dairy, beef,
unknown), and state within Mexico or USA from which the case
originated. For each cohort, cattle and human, we classiﬁed M.
bovis isolates with identical spoligotype patterns as clusters of
related strains. Isolates with spoligotypes that did not match any
other human or cattle spoligotypes were considered unrelated or
‘orphan strains’.24,29–32 All spoligotype patterns were submitted to
the public M. bovis spoligotype database (www.mbovis.org), and
given a unique identiﬁer number (SB number) to identify them in
this publication.
3. Results
We obtained a total of 106M. bovis genotypes from 109 human
M. bovis TB cases in San Diego County from 2004 through 2007
(spoligotypes for three cases could not be resolved). These human
M. bovis spoligotypes were compared to spoligotypes from 496M.
bovis isolates from Mexican cattle and 219M. bovis isolates from
US cattle.County from 2004 to 2007 showing matches to cattle originating in Mexico and the













ysis. Six out of the 106 cases could not be resolved by MIRU analysis.
Table 2
Total number ofMycobacterium bovis strains and spoligotypes reported from cattle originating in Mexico. Table ordered by number of cattle spoligotypes from eachMexican
state that matched human cases, 1997–2008.
State Number of isolates by cattle type Number of unique
spoligotypes (% per state)
Number of unique cattle spoligotypes
matching human spoligotypes in San
Diego (% matching per state)Dairy Beef Unknown Total (%)
Jalisco 39 5 17 61 (12.3) 48 (78.7) 5 (10.4)
Tamaulipas 1 23 5 29 (5.8) 11 (35.5) 4 (30.1)
Veracruz 0 5 18 23 (4.6) 12 (54.5) 4 (26.7)
Durango 0 25 5 30 (6.0) 13 (44.8) 4 (30.1)
Aguascalientes 13 15 2 30 (6.0) 18 (60.0) 4 (21.1)
Nueva Leon 0 22 7 29 (5.8) 17 (58.6) 4 (21.1)
Sonora 7 11 13 31 (6.3) 10 (32.3) 3 (25.0)
Chihuahua 65 17 10 92 (18.5) 17 (18.5) 3 (18.8)
Coahuila 0 9 3 12 (2.4) 6 (50.0) 3 (50.0)
Baja Californiaa 2 4 4 10 (2.0) 8 (80.0) 3 (37.5)
Campeche 0 3 0 3 (0.6) 2 (66.7) 2 (100)
Quere´taro 8 0 0 8 (1.6) 7 (88.9) 0 (0)
Mexico State 11 0 10 21 (4.2) 18 (85.7) 0 (0)
Unknownb 0 28 89 117 (23.6) 24 (21.2) 5 (26.3)
Total 146 167 183 496
a Baja California includes both Baja California and Baja California Sur.
b Cattle isolates obtained from animals for which state of origin was not available or untraceable.
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Twelve different spoligotype patterns were identiﬁed among
the 106 human cases in San Diego County from 2004 through 2007
(Table 1). Overall 98% (104/106) of cases were Hispanic; two cases
occurred in non-Hispanic whites. Sixty-two percent of cases (66/Table 3
Mycobacterium bovis spoligotypes reported among isolates from cattle originating from
No. of isolates, n
Spoligotype ID Spoligotype (octal) Dairy Beef
SB0673 264073777777600 9 51
SB0121 676773677777600 29 15
SB0140 664073777777600 10 18
SB0669 264063777777600 5 8
SB0145 640013777777600 4 16
SB0971 664073777700600 0 9
SB0269 664063777777600 2 2
SB0327 676573777077600 3 9
SB1165 640033777777600 0 3
SB0986 264071777777600 4 2
SB0663 640003777777600 4 0
SB1040 640013377777600 1 5
SB1116 664063777700600 2 2
SB0119 676763677777600 5 0
SB1044 064063777777600 4 0
SB1496 640023777777600 0 1
SB0272 664073777757600 3 1
SB0130 676573777777600 0 1
SB1111 064061777777600 3 0
SB1114 440003777777600 3 0
SB0987 624073777700600 3 0
SB1118 640003777776600 0 0
SB1216 076573777077600 0 3
SB1110 064263777777600 2 0
SB1696 444063777746600 1 1
SB1125 464063735546600 0 0
SB1113 464063777756600 0 0
SB1129 674563777077600 0 0
SB1503 674573777077600 0 1
SB0807 676773675777600 2 0
SB1757 644073777700600 0 2
SB1755 666073777777600 0 1
SB0152 400000077777600 0 1
Mutliplea Multiple 47 15
Total 146 167
a There are 94 isolates each represented by a single cow. Ninety-three did not match th
listed separately in this table since it was a match to human spoligotype SB0152.106) reported being born in Mexico while the remainder reported
being born in the USA.
Eighty-ﬁve percent (90/106) of the human M. bovis cases were
clustered in two spoligotypes, SB0145 and SB1040. Eleven of the
remaining 16 humanM. bovis cases were in clusters of two or three
isolates, and four cases had orphan spoligotypes that did notmatchMexico, 1997–2008
Unknown Total (% of all) Match to human cases
58 118 (23.8) Yes (SB0673)
4 48 (9.7) No
6 34 (6.9) Yes (SB0140)
18 31 (6.3) No
10 30 (6.0) Yes (SB0145)
9 18 (3.6) Yes (SB0971)
10 14 (2.8) No
2 14 (2.8) No
6 9 (1.8) No
2 8 (1.6) No
4 8 (1.6) No
2 8 (1.6) Yes (SB1040)
4 8 (1.6) No
0 5 (1.0) No
0 4 (0.8) No
3 4 (0.8) No
0 4 (0.8) No
3 4 (0.8) No
0 3 (0.6) No
0 3 (0.6) No
0 3 (0.6) No
3 3 (0.6) No
0 3 (0.6) No
0 2 (0.4) No
0 2 (0.4) No
2 2 (0.4) No
2 2 (0.4) No
2 2 (0.4) No
1 2 (0.4) No
0 2 (0.4) No
0 2 (0.4) No
1 2 (0.4) No
0 1 (0.2) Yes (SB0152)
31 93 No
183 496
e human isolates and were grouped together in this table as ‘Multiple’. SB0152 was
Table 4
Mycobacterium bovis spoligotypes collected from US cattle, 1997–2008, that
matched human M. bovis spoligotypes in San Diego
Spoligotype ID Spoligotype/state Number of isolates (%)
SB0673 264073777777600
New Mexico 78 (78.8)
California 6 (6.1)
Texas 5 (5.1)
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by MIRU subtype into 22 different strain types. The MIRU pattern
for six out of the 106 human isolates could not be resolved.
3.2. Mycobacterium bovis isolates from cattle
M. bovis genotypes were obtained from Mexican cattle
populations in 13 of 31 Mexican states (Table 2). The majority
were fromChihuahua (n = 92) and Jalisco (n = 61), and the northern
and easternMexican states. Baja California contributed 10 isolates.
We could not determine the state of origin for 117 Mexican cattle
genotypes.
Of 496M. bovis cases in Mexican cattle, we identiﬁed 126
different spoligotype patterns. Ninety-three Mexican cattle
spoligotypes were orphan strains (Table 3). Approximately one
third (146/496) of Mexican cattle tested were dairy cattle and one
third were beef cattle (167/496). The breeding purpose for 37%
(183/496) of cattle tested was unknown.
3.3. Human/cattle spoligotype matches
Over 91% (97/106) of the humanM. bovis TB isolates from San
Diego County had spoligotypes that were identical to those
found in Mexican cattle (Table 1). Four human cases hadM. bovis
spoligotypes that matched cattle originating from both Mexico
and the USA, and nine human cases had spoligotypes that did
not match cattle in Mexico or the USA. Eleven of the 13 Mexican
states sampled yielded cattle M. bovis isolates with spoligotypes
that matched human M. bovis spoligotypes in San Diego
(Table 2).
Human M. bovis spoligotypes SB0145, SB1040, SB0152, and
SB0971, which accounted for 88% (93/106) of all the human cases,Figure 1.Mexican states where cattle were sampled forMycobacterium bovis (gray shadin
in each state sampled. States shaded in light gray indicate Mexican states in whichM. bowere found in only 11.5% of the Mexican cattle sampled (Table 3),
but were found widely distributed in all but two of the Mexican
states sampled (Figure 1). Human M. bovis spoligotypes SB0673
and SB0140, found in both Mexican and US cattle, accounted for
only 3.8% of the human cases, but were found in 31% (152/496) of
M. bovis isolates obtained fromMexican cattle (Table 3), and in 45%
(99/219) of US cattle tested (Table 4).
4. Discussion
Our analyses indicate that the majority of human M. bovis
pathogen strains identiﬁed in San Diego from 2004 through
2007 had the same spoligotype as strains found only in cattle in
Mexico, supporting existing epidemiological evidence7–14 that
the population of M. bovis strains causing human M. bovis
disease in this region most likely originated in Mexican cattle.
Most of the human M. bovis cases with spoligotypes matchingg). Letters represent the San Diego humanM. bovis spoligotypes that matched cattle
viswas found in cattle but their spoligotypes did not match San Diego human cases.
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related patterns (SB0145 and SB1040). These spoligotypes were
rare among the sampled Mexican cattle, but widely distributed
across 11 of the 13 Mexican states sampled, and were not
detected among the US cattle surveillance cohort. This lack of
concordance in the frequency of M. bovis strains circulating in
the suspected animal source population relative to the strains
circulating in humans has been documented in other countries
where M. bovis is a zoonotic disease.33–35 It is possible that the
discordance observed is a sampling artifact as the Mexican cattle
spoligotypes represent only a small proportion of the approxi-
mately 23 million head of cattle in Mexico, but it might also
reﬂect changes in the Mexican cattle population that occurred
between the time the human infections were acquired and the
time the infections reactivated as TB disease, as has been
documented in the UK.36 It is also possible that human M. bovis
strains SB0145 and SB1040, which differ by only a single
spoligotype spacer, have been spread from person-to-person,
which would increase their frequency.
While person-to-person transmission of M. bovis has recently
been demonstrated in France37 and the UK38 and has been
hypothesized to be occurring in San Diego,11,12 there is consider-
able epidemiological evidence in San Diego that indicates person-
to-person transmission is probably rare, despite the fact that
approximately 54% ofM. bovis cases in this region have pulmonary
disease.13 This evidence includes the absence ofM. bovis TB cases in
children not yet exposed to dairy products (these children do get
M. tuberculosis TB which is only transmitted person-to-person);10
and the evidence that M. bovis incidence in San Diego, which
increased signiﬁcantly from 1994 through 2005, has not followed
the same trends as M. tuberculosis incidence, which has steadily
decreased since 1994. This suggests that M. bovis transmission
mechanisms are different from the person-to-person transmission
of M. tuberculosis.13
The two spoligotypes from four human cases that matched
strains from Mexican and US cattle (SB0673 and SB0140), were
common in Mexican cattle, and were also found in cattle from six
different states in the USA, including California. It is not surprising
that some of the spoligotypes examined were present in cattle
from both sides of the border. Restrictions on cattle trade between
Mexico and the USA have only been in place for 10 years, and only
prevent the importation of dairy cattle into the USA.20 Beef cattle
can still be exported from Mexico into the USA if they are
demonstrated to be tuberculin skin test (TST)-negative at the time
of export.
Since the US bovine TB eradication program began in 1917, M.
bovis infection in US cattle has been extremely rare.4 Less than
0.02% of US cattle tested positive for TB by TST in 2002,39 and less
than 0.002% of 377 000 cattle tested in a 2008 California M. bovis
investigation were positive for TB.40 Localized M. bovis outbreaks,
low prevalence of M. bovis infection in US cattle herds, and strict
national pasteurization requirements in the USA make it unlikely
that the San Diego human cases with SB0673 and SB0140
spoligotypes are associated with US-born cattle with these
spoligotypes.
In contrast, there have been several reports of widespread M.
bovis infection in Mexican cattle.18–21,23,32,41 In some regions of
Mexico, up to 13% of dairy herds are reported to be infectedwithM.
bovis42 and up to 30% of milk produced in Mexico is not
pasteurized.19 Additionally, unpasteurized soft fresh cheeses, such
as queso fresco, which is very popular within the Mexican
community, are brought into the USA from Mexico for personal
use and have been shown to be contaminated with M. bovis,14,15
making it much more likely that human cases with SB0673 and
SB0140 spoligotypes are associatedwithMexican cattle with those
spoligotypes.4.1. Limitations
While spoligotyping is a practical approach for genotyping in
large scale, population-level M. bovis studies such as this one, it is
not a complete tool for molecular epidemiological analyses.43
Spoligotyping requires less DNA than other methods, is easily
replicated in low-resource settings, and results can be digitally
expressed,25,30,44,45 but, it can have limited discriminatory power if
used in isolation.46
While we were able to obtain MIRU data for all of the human
M. bovis cases, which demonstrated some heterogeneity
amongst the human spoligotype clusters, it was not possible,
due to the retrospective nature of the study and the lack of
access to the cattle isolates, to obtain MIRU data for any of the
cattle cases. However, we do not believe that the lack of MIRU
data limited our conclusion that the population of human M.
bovis strains from San Diego likely originated from the
population of M. bovis strains found in Mexican cattle, as that
is the most parsimonious conclusion from all of the available
molecular and epidemiological data. We could not exclude the
possibility of homoplasy, where similar mutations in the human
and cattle M. bovis strains could have arisen in phylogenetically
unrelated strains. But given the clonal nature of M. bovis, the
approximately 10–20 year stability of spoligotypes and the
unidirectionality of mutations in the DR region (spacers can only
be lost not re-acquired),36 the likelihood of signiﬁcant homo-
plasy in our binational pathogen populations is remote in the
time-period under study. Additional MIRU and restriction
fragment length polymorphism sub-typing, based on a sys-
tematic cattle sample, to further distinguish strains, are needed
to determine the contribution of speciﬁc dairy sources to
speciﬁc human cases in the USA.
Little can be inferred from the nine human M. bovis cases that
did not match any of the cattle cases fromMexico or the USA. It is
very unlikely that these casesmatch undetected cattle cases in the
USA as the US cattle sample represents all known cattle TB
suspects from1997 through 2008. The same cannot be said for the
Mexican sample. It represents only a small fraction of incidentM.
bovis cases among cattle in Mexico and additional matching
strains may have gone undetected. Furthermore, the use of a
convenience sample of cattle isolates from Mexico may have
introduced a selection bias.
5. Conclusions
Our genotyping data indicate that the population of M. bovis
strains causing humanM. bovis TB disease in Southern California is
closely related to the M. bovis strain population found in Mexican
cattle and supports existing epidemiological evidence10,13 that
humanM. bovis TB in San Diego likely originates in Mexican cattle.
This suggests that elimination of M. bovis TB in San Diego will
require a reduction in M. bovis prevalence in Mexican cattle,
increasing pasteurization of milk products inMexico, and reducing
the ﬂow of unpasteurized milk products between Mexico and the
USA.
The California State and San Diego County Health Departments
have long standing enforcement programs that target the illegal
sale of dairy products, in addition to providing educational
resources regarding the risks of unpasteurized dairy products.
Furthermore, in 2008, the San Diego Health Department initiated a
media campaign to educate the Hispanic community on both sides
of the border about prevention of TB from M. bovis; however,
studies to evaluate the effectiveness of these efforts have not been
completed.
Restriction of importation of unpasteurized cheeses for
personal use is also being tested at the region’s USA–Mexico
T.C. Rodwell et al. / International Journal of Infectious Diseases 14S (2010) e129–e135e134border,47 and may assist in reducing exposures in the USA if found
feasible to implement. However, since exposure will likely
continue via consumption of dairy products in Mexico, it is critical
that binational cooperation and resources for collaboration be
made available in the USA andMexico in order to eradicateM. bovis
fromMexican dairy herds. Our analysis indicates thatmostM. bovis
strain clusters are found throughout Mexico, suggesting that
unrestricted cattle movement in the past has played a role in M.
bovis transmission in Mexico. In order to fully address M. bovis TB
infections in Mexican cattle, preventionmeasures that incorporate
a nationwide approach will be required. Increased emphasis on
pasteurization of most dairy products could also assist in
prevention efforts.
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